logo
  • About Us
    • Our Company
    • Leadership
    • Contact
    • Medical Education Grants
  • Product
    Candidates
    • Pipeline VP-102
    • Pipeline VP-103
    • Pipeline LTX-315
    • R & D
    • Key Publications
  • Investors &
    Media
    • Investor Overview
    • Press Releases
    • Analyst Coverage
    • Presentations & Events
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Connection
  • Careers
Menu
  • About Us
    • Our Company
    • Leadership
    • Contact
    • Medical Education Grants
  • Product
    Candidates
    • Pipeline VP-102
    • Pipeline VP-103
    • Pipeline LTX-315
    • R & D
    • Key Publications
  • Investors &
    Media
    • Investor Overview
    • Press Releases
    • Analyst Coverage
    • Presentations & Events
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Connection
  • Careers

SEC Filing Group: Registration Statements

0001193125-22-144468

1-00001193125-21-155019

0001193125-21-091358

0001193125-21-089577

157-S-3 -20200313

158-S-8 -20200313

99-S-8 -20190507

26-S-8 -20180713

17-424B4 -20180615

4-8-A12B -20180613

← older
About Us
  • Our Company
  • Leadership
  • Contact
  • Medical Education Grants
Product Candidates
  • Pipeline VP-102
  • Pipeline VP-103
  • Pipeline LTX-315
  • R & D
  • Key Publications
Investors & Media
  • Investor Overview
  • Press Releases
  • Analyst Coverage
  • Presentations & Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor FAQs
  • Investor Connection
Careers
  • Terms of Use
  • Privacy Policy
logo
Twitter Linkedin-in Facebook-f
© 2022 Verrica Pharmaceuticals.